Van Dorsselaer; Viviane

Patent Applications and Registrations

Patent applications and USPTO patent grants for Van Dorsselaer; Viviane.The latest application filed is for "derivatives of pyrazole 3,5-carboxylates, their preparation and their application in therapeutics".

Company Profile

0.11.11

Van Dorsselaer; Viviane - Paris N/A FR
Van Dorsselaer; Viviane - Strasbourg FR

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Derivatives of pyrazole 3,5-carboxylates, their preparation and their application in therapeutics Grant 9,102,628 - Foricher , et al. August 11, 2	2015-08-11
Therapeutic use of acylaminothiazole derivatives Grant 7,879,889 - Despey-Roux , et al. February 1, 2	2011-02-01
Use of acylaminothiazole derivatives as therapeutic agents Grant 7,795,289 - Baltzer , et al. September 14, 2	2010-09-14
Acylaminothiazole derivatives and use thereof as beta-amyloid inhibitors Grant 7,759,377 - Baltzer , et al. July 20, 2	2010-07-20
Derivatives Of Pyrazole 3,5-carboxylates, Their Preparation And Their Application In Therapeutics App 20100160377 - FORICHER; Yann ; et al.	2010-06-24
Therapeutic Use of Acylaminothiazole Derivatives App 20090253753 - DESPEYROUX; Pierre ; et al.	2009-10-08
Acylaminothiazole derivatives, preparation method thereof and use of same in therapeutics Grant 7,582,664 - Baltzer , et al. September 1, 2	2009-09-01
Acylaminothiazole derivatives, their preparation and their therapeutic use Grant 7,563,903 - Despeyroux , et al. July 21, 2	2009-07-21
Acylaminothiazole Derivatives And Use Thereof As Beta-amyloid Inhibitors App 20080176911 - BALTZER; Sylvie ; et al.	2008-07-24
Acylaminothiazole derivatives and use thereof as .beta.-amyloid inhibitors Grant 7,371,770 - Baltzer , et al. May 13, 2	2008-05-13
Use of Acylaminothiazole Derivatives as Therapeutic Agents App 20080051436 - BALTZER; Sylvie ; et al.	2008-02-28
Acylaminothiazole derivatives, preparation and therapeutic use thereof Grant 7,291,636 - Baltzer , et al. November 6, 2	2007-11-06
Acylaminothiazole Derivatives, Preparation Method Thereof And Use Of Same In Therapeutics App 20060293365 - BALTZER; Sylvie ; et al.	2006-12-28
Acylaminothiazole Derivatives And Use Thereof As Beta-amyloid Inhibitors App 20060293366 - Baltzer; Sylvie ; et al.	2006-12-28
Acylaminothiazole derivatives, their preparation and their therapeutic use App 20060052426 - Despeyroux; Pierre ; et al.	2006-03-09
Benzimidazole derivatives, preparation and therapeutic use thereof Grant 6,979,683 - Barth , et al. December 27, 2	2005-12-27
Acylaminothiazole derivatives, preparation and therapeutic use thereof App 20050182104 - Balter, Sylvie ; et al.	2005-08-18
Benzimidazole derivatives, preparation and therapeutic use thereof App 20050032779 - Barth, Francis ; et al.	2005-02-10
Benzimidazole derivatives, preparation and therapeutic use thereof Grant 6,794,382 - Barth , et al. September 21, 2	2004-09-21
Benzimidazole derivatives, preparation and therapeutic use thereof App 20040029866 - Barth, Francis ; et al.	2004-02-12
Benzimidazole derivatives, preparation and therapeutic use thereof App 20030203893 - Barth, Francis ; et al.	2003-10-30

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.